MedPath
HSA Approval

COUGH-EN LINCTUS

SIN08780P

COUGH-EN LINCTUS

COUGH-EN LINCTUS

July 3, 1996

APEX PHARMA MARKETING PTE. LTD.

APEX PHARMA MARKETING PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantAPEX PHARMA MARKETING PTE. LTD.
Licence HolderAPEX PHARMA MARKETING PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Pharmacy Only
HSA Singapore Classification

Formulation Information

ELIXIR

ORAL

Medical Information

R05DA20

combinations

Manufacturer Information

APEX PHARMA MARKETING PTE. LTD.

XEPA-SOUL PATTINSON (MALAYSIA) SDN BHD

Active Ingredients

DEXTROMETHORPHAN HBr

15 mg/5 ml

Dextromethorphan

TRIPROLIDINE HCl

1.25 mg/5 ml

Triprolidine

PSEUDOEPHEDRINE HCl

30 mg/5 ml

Pseudoephedrine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.